Skip to main content

Table 1 Optimization mobile phase and column in method development

From: A novel UPLC-PDA isocratic method for the quantification fulvestrant in oil-based pre-filled syringe injection matrix formulations

Trail no.

Mobile phase composition

Column

Observation

Inference

1

Monobasic sodium phosphate: acetonitrile (60:40 v/v)

ACQUITY UPLC HSST3 100 mm × 1 mm 1.8 μm

Delta (6,7) fulvestrant impurity not separated from fulvestrant

Method rejected

2

0.1% v/v TEA: acetonitrile (60:40 v/v)

ACQUITY UPLC HSST3 100 mm × 1 mm 1.8 μm

Impurities are not separated from fulvestrant peak

Method rejected

3

0.1% v/v OPA: methanol (600:400 v/v/v)

ACQUITY UPLC Phenyl 150 mm × 2.1 mm 1.7 μm

Impurities are separated from fulvestrant. But sulfone impurity was eluted very late

Method rejected

4

0.1% v/v OPA: acetonitrile: methanol (300:400:300 v/v/v)

ACQUITY UPLC Phenyl 150 mm × 2.1 mm 1.7 μm

Impurities are not well separated from fulvestrant

Method rejected

5

0.1% v/v OPA: acetonitrile and methanol (300;400;300 v/v/v)

BEH shield RP18, 50 mm × 2.1 mm 1.7 μm

Impurities are well separated from fulvestrant with good peak shape and less run time

Approved